KR960702310A - 도파민 재소비 저해제 - Google Patents

도파민 재소비 저해제

Info

Publication number
KR960702310A
KR960702310A KR1019950705267A KR19950705267A KR960702310A KR 960702310 A KR960702310 A KR 960702310A KR 1019950705267 A KR1019950705267 A KR 1019950705267A KR 19950705267 A KR19950705267 A KR 19950705267A KR 960702310 A KR960702310 A KR 960702310A
Authority
KR
South Korea
Prior art keywords
inhibitor
dopamine
hydrogen
reincorporation
acyl
Prior art date
Application number
KR1019950705267A
Other languages
English (en)
Other versions
KR100307660B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR960702310A publication Critical patent/KR960702310A/ko
Application granted granted Critical
Publication of KR100307660B1 publication Critical patent/KR100307660B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Finger-Pressure Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019950705267A 1993-06-25 1994-04-28 도파민재소비저해제 KR100307660B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15556493 1993-06-25
JP155564/1993 1993-06-25
PCT/JP1994/000728 WO1995000149A1 (fr) 1993-06-25 1994-04-28 Inhibiteur de reincorporation de dopamine

Publications (2)

Publication Number Publication Date
KR960702310A true KR960702310A (ko) 1996-04-27
KR100307660B1 KR100307660B1 (ko) 2001-12-28

Family

ID=15608814

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950705267A KR100307660B1 (ko) 1993-06-25 1994-04-28 도파민재소비저해제

Country Status (13)

Country Link
US (1) US5747493A (ko)
EP (1) EP0706796B1 (ko)
JP (1) JP3062249B2 (ko)
KR (1) KR100307660B1 (ko)
AT (1) ATE199318T1 (ko)
AU (1) AU674955B2 (ko)
CA (1) CA2163986A1 (ko)
DE (1) DE69426771T2 (ko)
DK (1) DK0706796T3 (ko)
ES (1) ES2157258T3 (ko)
GR (1) GR3035688T3 (ko)
PT (1) PT706796E (ko)
WO (1) WO1995000149A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives
US4469695A (en) * 1980-02-25 1984-09-04 Ayerst, Mckenna & Harrison, Inc. 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
CS271571B1 (en) * 1987-12-10 1990-10-12 Protiva Miroslav Piperazine derivatives, their salts and method of their preparation
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
EP0365064B1 (en) * 1988-10-10 1992-10-21 Akzo N.V. Substituted aromatic compounds having an action on the central nervous system
DK0385237T3 (da) * 1989-03-03 1994-07-25 Dainippon Pharmaceutical Co 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem
JPH0747574B2 (ja) * 1989-03-03 1995-05-24 大日本製薬株式会社 ピリジン誘導体及びそれを有効成分とする向精神剤
TW205034B (ko) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
US5089497A (en) * 1990-09-20 1992-02-18 Warner-Lambert Company Substituted piperazines as central nervous system agents
CA2067475C (en) * 1991-05-08 2000-10-10 Yasuo Oshiro Carbostyril derivatives and their use

Also Published As

Publication number Publication date
US5747493A (en) 1998-05-05
DE69426771D1 (de) 2001-04-05
ATE199318T1 (de) 2001-03-15
EP0706796A4 (en) 1999-03-24
EP0706796B1 (en) 2001-02-28
EP0706796A1 (en) 1996-04-17
KR100307660B1 (ko) 2001-12-28
AU6689194A (en) 1995-01-17
DE69426771T2 (de) 2001-06-13
DK0706796T3 (da) 2001-03-26
CA2163986A1 (en) 1995-01-05
GR3035688T3 (en) 2001-07-31
JP3062249B2 (ja) 2000-07-10
AU674955B2 (en) 1997-01-16
PT706796E (pt) 2001-06-29
ES2157258T3 (es) 2001-08-16
WO1995000149A1 (fr) 1995-01-05

Similar Documents

Publication Publication Date Title
DK0516941T3 (da) Pyrazolopyridinforbindelser og fremgangsmåder til fremstilling deraf
NO911525D0 (no) Nye 2,9-disubstituerte-4h-pyrido(1,2-a)pyrimidin-4-oner.
ATE247089T1 (de) Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
DE69104615D1 (de) Diphenylpiperazinderivat.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
FR2672801B1 (fr) Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
DE69029693T2 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
DK0420121T3 (da) Antitumormiddel
EP0546177A4 (en) BENZOPYRANE DERIVATIVE, PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME.
FI935799A0 (fi) Arylsubstituerade heterocykliska foereningar
KR960702310A (ko) 도파민 재소비 저해제
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
MX9206930A (es) Nuevos compuestos
DK0420224T3 (da) Anthihepatopatisk middel
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
NO20006065D0 (no) Cyanoiminokinoksalinderivater
DE3884878D1 (de) Uricosuretische Zusammensetzung.
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee